| Susan Krissel, CNM | |
|
3180 Main St, Suite 202, Bridgeport, CT 06606-4237 | |
| (203) 374-0404 | |
| (203) 372-4167 |
| Full Name | Susan Krissel |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 3180 Main St, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982020475 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 389 (Connecticut) | Primary |
| Entity Name | Planned Parenthood Of Southern New England Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174633143 PECOS PAC ID: 3173436730 Enrollment ID: O20031110000416 |
News Archive
People who participate in arts and craft activities and who socialize in middle and old age may delay the development in very old age of the thinking and memory problems that often lead to dementia, according to a new study published in the April 8, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
XenoPort announced today that new data from clinical trials of its product candidates arbaclofen placarbil and XP13512 (gabapentin enacarbil) will be presented at the 62nd Annual American Academy of Neurology meeting in Toronto, Ontario.
SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of late-stage pharmaceutical products focused on the treatment of pain, announced today that it has completed patient enrollment for the dermal safety studies and the pivotal pharmacokinetic study related to its investigational product Ztlido (lidocaine patch 1.8%), a next-generation branded lidocaine patch for the treatment of postherpetic neuralgia, also referred to as "after-shingles pain."
A new type of antibody test is being developed by researchers at Linnaeus University and the bioanalysis company Attana. Compared to the binary antibody tests used today, this rapid test can give more detailed information on how our immune systems react to Covid-19 and other types of viruses and bacteria.
A new study of more than 150 COVID-19 patients shows that IgA antibodies dominate the early response to the SARS-CoV-2 virus, coming on more quickly and strongly than IgG and IgM antibodies. This is a somewhat unexpected result, as IgM antibodies are usually the immune system's first responders.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susan Krissel, CNM 3180 Main St, Suite 202, Bridgeport, CT 06606-4237 Ph: () - | Susan Krissel, CNM 3180 Main St, Suite 202, Bridgeport, CT 06606-4237 Ph: (203) 374-0404 |
News Archive
People who participate in arts and craft activities and who socialize in middle and old age may delay the development in very old age of the thinking and memory problems that often lead to dementia, according to a new study published in the April 8, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
XenoPort announced today that new data from clinical trials of its product candidates arbaclofen placarbil and XP13512 (gabapentin enacarbil) will be presented at the 62nd Annual American Academy of Neurology meeting in Toronto, Ontario.
SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of late-stage pharmaceutical products focused on the treatment of pain, announced today that it has completed patient enrollment for the dermal safety studies and the pivotal pharmacokinetic study related to its investigational product Ztlido (lidocaine patch 1.8%), a next-generation branded lidocaine patch for the treatment of postherpetic neuralgia, also referred to as "after-shingles pain."
A new type of antibody test is being developed by researchers at Linnaeus University and the bioanalysis company Attana. Compared to the binary antibody tests used today, this rapid test can give more detailed information on how our immune systems react to Covid-19 and other types of viruses and bacteria.
A new study of more than 150 COVID-19 patients shows that IgA antibodies dominate the early response to the SARS-CoV-2 virus, coming on more quickly and strongly than IgG and IgM antibodies. This is a somewhat unexpected result, as IgM antibodies are usually the immune system's first responders.
› Verified 5 days ago
Patricia Marciano, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 982 E Main St, Bridgeport, CT 06608 Phone: 203-696-3260 Fax: 203-332-0376 | |
Wilhelmina G Thomas-jackson, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 226 Mill Hill Ave, 3rd Floor, Bridgeport, CT 06610 Phone: 203-384-3873 Fax: 203-384-3829 | |
Mrs. Mary Schwartzman, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 625 Clinton Ave, Bridgeport, CT 06605 Phone: 203-333-8857 | |
Ms. Jacqueline Ann Young, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 4675 Main St, Bridgeport, CT 06606 Phone: 203-372-9998 Fax: 203-373-9095 | |
Ms. Janet Spinner, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 361 Bird St, Bridgeport, CT 06605 Phone: 203-330-6000 Fax: 203-330-5003 | |
Brenda I Kulikowski, MSN; CERTIFIED NURSE Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 982 East Main Street, Optimus Health Care, Bridgeport, CT 06608 Phone: 203-696-3260 Fax: 203-696-3250 | |
Deborah Ruth Johnson, C.N.M. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 509 Park Ave, Bridgeport, CT 06604 Phone: 203-330-6000 |